Case 966-- Clinical Chemistry Case
How to get clearer test results on monoclonal antibodies
Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
Diagnostics | Free Full-Text | Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment
PathPointer: Membranous-Like Glomerulopathy With Masked IgG Kappa Deposits – AJKD Blog
Case 966-- Clinical Chemistry Case
A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation | Neurology Neuroimmunology & Neuroinflammation
IgG Kappa Binding Protein HRP Conjugate - Molecular Depot
Frontiers | Daratumumab for the Treatment of Multiple Myeloma
Types of Multiple Myeloma | International Myeloma Foundation
Immunophenotypic analyses of the MMLAL cells. The MMLAL | Open-i
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Unlabeled Anti-Mouse Kappa, 187.1 | SouthernBiotech
Different antibody-based therapies for treatment of multiple myeloma:... | Download Scientific Diagram
Human IgG Kappa MAb HTRF kit | Cisbio
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
Anti Human Kappa Chain, made in goat, AMCA labeled x human
Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa deposits - ScienceDirect
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
Immunoelectrophoresis ofproducts released after treatment ofIgG-bearing... | Download Scientific Diagram
Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab - Sally Thirkettle, Joanne Russell, Sarah Wilson, Tasneem Ganijee, Samar Kulkarni, Jim Cavet, Phillip J Monaghan,
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
